Abstract
Successful islet isolation is the key to islet transplantation in diabetic patients. However, islet isolation is a technically complex and time-consuming manual process. Optimizing the islet isolation process can improve islet yield and quality, reduce operators, and thus reduce costs.
The isolation and purification of human islets include pancreas acquisition and preservation, pancreas digestion, islet purification, islet culture, and islet quality identification. Briefly, after the duodenum was removed, the pancreas was trimmed, the main pancreatic duct was intubated at the distal end of the pancreatic head, collagenase was injected into the pancreatic duct, and the perfused pancreatic tissue was cut and then digested in a Ricordi chamber. A digestion temperature of 37 °C was continuously used to assess the number of samples and the integrity of the lysed and released islets. At the end of the digestion process, collect the digested tissue in a 500 mL centrifuge tube prefilled with 25 mL of cold (4 °C) human serum albumin and centrifuge twice at 150 g for 3 min. After mixing with UW solution as islet storage solution, put it on ice (shake occasionally to prevent clumping) after 30 min. Digested pancreatic tissue was centrifuged at 2200 rpm for 5 min in a COBE 2991 cell processor to isolate islets from exocrine tissue using a continuous density gradient. The purified islet fractions were washed twice in HBSS supplemented with 10% human serum albumin and finally collected in CMRL1066 medium supplemented with the corresponding liquid. The purity of purified islets was calculated by DTZ staining, the survival rate of islets was calculated by FDA/PI staining, and islet function was determined by in vitro glucose-stimulated insulin secretion test.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238
Robertson RP (2015) Islet transplantation for type 1 diabetes, what have we learned from alloislet and autoislet successes? Diabetes Care 38:1030–1035
Lablanche S, Borot S, Wojtusciszyn A, Bayle F, Tetaz R, Badet L, Thivolet C, Morelon E, Frimat L, Penfornis A, Kessler L, Brault C, Colin C, Tauveron I, Bosco D, Berney T, Benhamou PY (2015) Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL network. Diabetes Care 38:1714–1722
Bartlett ST, Markmann JF, Johnson P, Korsgren O, Hering BJ, Scharp D, Kay TW, Bromberg J, Odorico JS, Weir GC, Bridges N, Kandaswamy R, Stock P, Friend P, Gotoh M, Cooper DK, Park CG, O’Connell P, Stabler C, Matsumoto S, Ludwig B, Choudhary P, Kovatchev B, Rickels MR, Sykes M, Wood K, Kraemer K, Hwa A, Stanley E, Ricordi C, Zimmerman M, Greenstein J, Montanya E, Otonkoski T (2016) Report from IPITA-TTS opinion leaders meeting on the future of beta-cell replacement. Transplantation 100(Suppl 2):S1–S44
Shapiro AM, Pokrywczynska M, Ricordi C (2017) Clinical pancreatic islet transplantation. Nat Rev Endocrinol 13:268–277
Ricordi C, Lacy PE, Scharp DW (1989) Automated islet isolation from human pancreas. Diabetes 38(Suppl 1):140–142
Niclauss N, Bosco D, Morel P, Demuylder-Mischler S, Brault C, Milliat-Guittard L, Colin C, Parnaud G, Muller YD, Giovannoni L, Meier R, Toso C, Badet L, Benhamou PY, Berney T (2011) Influence of donor age on islet isolation and transplantation outcome. Transplantation 91:360–366
Meier RP, Sert I, Morel P, Muller YD, Borot S, Badet L, Toso C, Bosco D, Berney T (2014) Islet of Langerhans isolation from pediatric and juvenile donor pancreases. Transpl Int 27:949–955
Matsumoto S, Zhang G, Qualley S, Clever J, Tombrello Y, Strong DM, Reems JA (2004) Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 36:1034–1036
Balamurugan AN, Naziruddin B, Lockridge A, Tiwari M, Loganathan G, Takita M, Matsumoto S, Papas K, Trieger M, Rainis H, Kin T, Kay TW, Wease S, Messinger S, Ricordi C, Alejandro R, Markmann J, Kerr-Conti J, Rickels MR, Liu C, Zhang X, Witkowski P, Posselt A, Maffi P, Secchi A, Berney T, O’Connell PJ, Hering BJ, Barton FB (2014) Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant 14:2595–2606
Szot GL, Lee MR, Tavakol MM, Lang J, Dekovic F, Kerlan RK, Stock PG, Posselt AM (2009) Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation 88:753–756
Perrier Q, Lavallard V, Pernin N, Wassmer CH, Cottet-Dumoulin D, Lebreton F, Bellofatto K, Andres A, Berishvili E, Bosco D, Berney T, Parnaud G (2021) Failure mode and effect analysis in human islet isolation: from the theoretical to the practical risk. Islets 13:1–9
Doppenberg JB, Engelse M, de Koning E (2021) PRISM: a novel human islet isolation technique. Transplantation. https://doi.org/10.1097/TP.0000000000003897. Online ahead of print
Ricordi C, Finke EH, Lacy PE (1986) A method for the mass isolation of islets from the adult pig pancreas. Diabetes 35:649–653
Lake SP, Bassett PD, Larkins A, Revell J, Walczak K, Chamberlain J (1989) Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 38(Suppl 1):143–145
Vargas F, Vives-Pi M, Somoza N, Alcalde L, Armengol P, Marti M, Serradell L, Costa M, Fernandez-Llamazares J, Sanmarti A, Pujol-Borrell R (1996) Advantages of using a cell separator and metrizamide gradients for human islet purification. Transplantation 61:1562–1566
Rilo HL, Phipps J, Dedousis N, Watkins S, Kirsch D, Carroll PB, Rao AS (1994) Comparison of human islet number and viability obtained during purification on Euro-Collins-Ficoll gradients processed on a refrigerated or nonrefrigerated COBE 2991 cell separator. Transplant Proc 26:3430
Huang GC, Zhao M, Jones P, Persaud S, Ramracheya R, Lobner K, Christie MR, Banga JP, Peakman M, Sirinivsan P, Rela M, Heaton N, Amiel S (2004) The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation 77:143–145
Squifflet JP, LeDinh H, de Roover A, Meurisse M (2011) Pancreas preservation for pancreas and islet transplantation: a minireview. Transplant Proc 43:3398–3401
Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Rajotte RV (1999) Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8:285–292
Klaffschenkel RA, Biesemeier A, Waidmann M, Northoff H, Steurer W, Konigsrainer A, Lembert N (2007) A closed system for islet isolation and purification using the COBE2991 cell processor may reduce the need of clean room facilities. Cell Transplant 16:587–594
van der Burg MP, Graham JM (2003) Iodixanol density gradient preparation in university of wisconsin solution for porcine islet purification. Sci World J 3:1154–1159
Delle H, Saito MH, Yoshimoto PM, Noronha IL (2007) The use of iodixanol for the purification of rat pancreatic islets. Transplant Proc 39:467–469
Howard JM, Moss NH, Rhoads JE (1950) Hyperinsulinism and islet cell tumors of the pancreas; with 398 recorded tumors. Int Abstr Surg 90:417–455
Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R, Et A (1990) Islet isolation assessment in man and large animals. Acta Diabetol Lat 27:185–195
Hawthorne WJ (2016) Necessities for a clinical islet program. Adv Exp Med Biol 938:67–88
Lakey JR, Warnock GL, Rajotte RV, Suarez-Alamazor ME, Ao Z, Shapiro AM, Kneteman NM (1996) Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 61:1047–1053
O’Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan E, Shapiro AM, Lakey JR (2005) The standardization of pancreatic donors for islet isolation. Transplant Proc 37:1309–1310
Ihm SH, Matsumoto I, Sawada T, Nakano M, Zhang HJ, Ansite JD, Sutherland DE, Hering BJ (2006) Effect of donor age on function of isolated human islets. Diabetes 55:1361–1368
Henquin JC (2018) Influence of organ donor attributes and preparation characteristics on the dynamics of insulin secretion in isolated human islets. Phys Rep 6:e13646
Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AM (2002) Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 73:1106–1110
Shindo Y, Levy MF, Kanak MA (2019) Evaluation of pancreatic duct cannulation methods for human islet isolation. Transpl Int 32:225–227
Takita M, Matsumoto S, Noguchi H, Shimoda M, Chujo D, Sugimoto K, Itoh T, Lamont JP, Lara LF, Onaca N, Naziruddin B, Klintmalm GB, Levy MF (2010) One hundred human pancreatic islet isolations at Baylor Research Institute. Proc (Baylor Univ Med Cent) 23:341–348
Gray DW, Morris PJ (1987) The use of fluorescein diacetate and ethidium bromide as a viability stain for isolated islets of Langerhans. Stain Technol 62:373–381
Ichii H, Inverardi L, Pileggi A, Molano RD, Cabrera O, Caicedo A, Messinger S, Kuroda Y, Berggren PO, Ricordi C (2005) A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 5:1635–1645
Wong WK, Jiang G, Sorensen AE, Chew YV, Lee-Maynard C, Liuwantara D, Williams L, O’Connell PJ, Dalgaard LT, Ma RC, Hawthorne WJ, Joglekar MV, Hardikar AA (2019) The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality. JCI Insight 4:e129299
Oancea AR, Omori K, Orr C, Rawson J, Dafoe DC, Al-Abdullah IH, Kandeel F, Mullen Y (2020) Inflammatory biomarkers in the blood and pancreatic tissue of organ donors that predict human islet isolation success and function. Islets 12:9–19
Nano R, Kerr-Conte JA, Scholz H, Engelse M, Karlsson M, Saudek F, Bosco D, Antonioli B, Bertuzzi F, Johnson P, Ludwing B, Ling Z, De Paep DL, Keymeulen B, Pattou F, Berney T, Korsgren O, de Koning E, Piemonti L (2020) Heterogeneity of human pancreatic islet isolation around Europe: results of a survey study. Transplantation 104:190–196
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Wei, L. (2023). Isolation and Purification of Human Pancreatic Islets. In: Moore, A., Wang, P. (eds) Type-1 Diabetes. Methods in Molecular Biology, vol 2592. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2807-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2807-2_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2806-5
Online ISBN: 978-1-0716-2807-2
eBook Packages: Springer Protocols